SEC Filing Details

Document Details

Form
8-K
Filing Date
Feb 16, 2024
Document Date
Feb 14, 2024
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Allogene Therapeutics
Issuer
Allogene Therapeutics, Inc.